Ring exchange at Roche’s top executive level
Schwan follows Franz, Schinecker follows Schwan.
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 246 entries already.
Schwan follows Franz, Schinecker follows Schwan.
Beckman Coulter Life Sciences announces that Suzanne Foster has been appointed as president of the company. She succeeds Greg Milosevich, who has left the company.
Jan Van den Bossche becomes the 20th partner of Andera Partners. He joined the Life Sciences team at the beginning of July to accelerate the deployment of its BioDiscovery 6 fund.
Lee Patterson joins UK-based Charnwood Molecular as new CEO. After nearly 25 years at UK-based Charnwood Molecular, Prof. Steve Allin has stepping down as CEO. He will remain as an investor and Board advisor.
COVID-19 is the acute pandemic, while antimicrobial resistance (AMR) is a silent, pandemic. New data makes the AMR pandemic visible, with the first global study of AMR estimating that 1.27 million people die from AMR every year, making AMR the 12th-leading cause of death globally.
The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.
The EchoLUTION Tissue DNA Kit from BioEcho was developed to isolate high-quality DNA in a short time, even from difficult-to-extract samples such as muscle and adipose tissue. Due to the significantly shorter lysis and reduced number of steps, the entire workflow is three to ten times faster than conventional methods that follow the bind-wash-elute principle.
VIB and Flemish Minister of Economy and Innovation, Hilde Crevits, announce the appointment of Dr Christine Durinx as VIB’s co-managing director, alongside Dr Jérôme Van Biervliet. Dr Jo Bury, co-founder and co-managing director since VIB’s inception 25 years ago, is passing the torch to Durinx who is the former Executive Director of the SIB Swiss Institute of Bioinformatics.
Building a sustainable future this is what drives us. We are passionate about making smart biotech materials part of everyday life. We believe nature offers better alternatives to existing materials with biofabricated technologies previously unimaginable – enabling our customers to make a true change.
The Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva.

